CSPC Pharmaceutical (1093.HK)
HKSE • Healthcare
January 21, 2026 at 08:00 UTC
Name
CEO
Website
Industry
Year Founded
Employees
CSPC Pharmaceutical Group is a healthcare company that researches, manufactures, and markets medicines through an integrated network of R&D centers, production sites, and distribution partners. The portfolio covers innovative therapies and well-established generics that address hospital and retail channels. Development teams progress candidates with a focus on clinical relevance and manufacturability rather than headline features. Commercial units coordinate medical education and supply so launches transition into stable availability. Manufacturing emphasizes quality systems and technology transfer that support consistent output across plants. The company serves domestic markets and selected international jurisdictions through registrations aligned with local standards. Within the pharmaceuticals sector, CSPC positions itself as a platform that links discovery with scaled delivery. Partnerships with ecosystem peers extend reach into specialty areas and adjacent services.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
CSPC Pharmaceutical's Technical Indicators Summary
The instrument 1093.HK exhibits a strong bullish trend, supported by a robust ADX reading near 40, indicating solid directional strength. Momentum remains positive as reflected by a moderately high RSI above 70, though it signals caution, while the MACD confirms upward momentum. The price consistently trades above its key moving averages, including the 200-day SMA, reinforcing the prevailing uptrend. Volume, as indicated by OBV, aligns with buying pressure, further validating the trend. Despite a relatively stable volatility reading from the ATR and the price hovering near the VWAP and classic pivot levels, the overall technical picture remains constructive. In summary, 1093.HK maintains a firm bullish stance with confirmed trend strength and momentum.
| Indicator | Value |
|---|---|
RSI (14) | 72.80 |
Stochastic %K (14, 3, 3) | 77.90 |
CCI (20) | 91.05 |
WPR (14) | -24.16 |
Momentum (10) | 0.87 |
MFI | 82.57 |
MACD Level (12, 26) | 0.47 |
Bollinger Bands | $7.93 - $10.21 |
ATR (14) | $0.34 (3.49%) |
ADX (14) | 39.81 |
OBV | 3,110,043,120 |
VWAP | $9.72 |
Classic Pivot Point | $9.77 |
Fibonacci Pivot Point | $9.77 |
Exponential Moving Averages | $7.80 - $9.52(5 indicators) |
Simple Moving Averages | $8.24 - $9.55(5 indicators) |
Get premium market insights delivered directly to your inbox.
The prior session ended on a brighter note for 1093.HK, which gained 3.38% at the close. The US Federal Reserve faces increased scrutiny amid threats of criminal investigations, impacting investor sentiment.
Price Change
from HK$ 9.46 close
+HK$ 0.32
Trading Volume
Above avg 110.1M
230.7M
vs S&P 500 Today
Moderate Outperformance
+0.16%
52-Week Position
Upper range
74.7%
Updated: January 13, 2026 at 13:15 UTC